Basics DexCom, Inc. DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. IPO Date: April 14, 2005 Sector: Healthcare Industry: Health Care Equipment and Supplies Market Cap: $25.54B Activated in VL: True Average Daily Range Avg Daily Range: $1.72 | 2.04% Avg Daily Range (30 D): $0.94 | 1.55% Avg Daily Range (90 D): $1.19 | 1.70% Institutional Daily Volume Avg Daily Volume: 1.05M Avg Daily Volume (30 D): 6.14M Avg Daily Volume (90 D): 4.83M Trade Size Avg Trade Size (Sh.): 72 Avg Trade Size (Sh.) (30 D): 67 Avg Trade Size (Sh.) (90 D): 64 Institutional Trades Total Inst.Trades: 19,449 Avg Inst. Trade: $7.18M Avg Inst. Trade (30 D): $5.55M Avg Inst. Trade (90 D): $6.5M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 5 Market Closing Trades Avg Closing Trade: $23.72M Avg Closing Trade (30 D): $46.49M Avg Closing Trade (90 D): $47.78M Avg Closing Volume: 348.48K     News Dec 6, 2025 @ 9:39 PM DXCM DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, E... Source: Rosen Law Firm Dec 5, 2025 @ 5:51 PM Lowey Dannenberg Notifies DexCom, Inc. (“Dex... Source: Lowey Dannenberg P.C. Dec 4, 2025 @ 8:48 PM DXCM Deadline Approaching on December 26, 2025: Ke... Source: Kessler Topaz Meltzer & Check, Llp Dec 2, 2025 @ 10:49 PM DXCM DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL,... Source: Rosen Law Firm Dec 1, 2025 @ 5:02 AM DXCM 截止日期提醒：... Source: Rosen Law Firm Financials   TTM Q3 2025 Q2 2025 Basic EPS $1.83 $.73 $.46 Diluted EPS $1.8 $.7 $.45 Revenue $ 4.52B $ 1.21B $ 1.16B Gross Profit $ 2.67B $ 731.4M $ 688.8M Net Income / Loss $ 720.7M $ 283.8M $ 179.8M Operating Income / Loss $ 777.7M $ 242.5M $ 212.6M Cost of Revenue $ 1.85B $ 477.9M $ 468.3M Net Cash Flow $ 1.21B $ 676.6M $ 254.2M PE Ratio 35.74     Splits Jun 13, 2022:   4:1